Derek Hicks - 20 Dec 2021 Form 3 Insider Report for Intellia Therapeutics, Inc. (NTLA)

Role: EVP, Chief Business Officer
Signature: /s/ James Basta, Attorney-in-fact
Issuer symbol: NTLA
Transactions as of: 20 Dec 2021
Net transactions value: $0
Form type: 3
Filing time: 29 Dec 2021, 15:20:26 UTC
Next filing: 05 Jan 2022
SEC: View on sec.gov

No securities are beneficially owned.

Remarks:

Exhibit 24 - Power of Attorney